Med Journal’s Breakthrough Of 2024: Anti-HIV Shot
Science.org reports:
Despite decades of progress, HIV still infects more than 1 million people a year, and a vaccine remains stubbornly out of reach. But this year the world got a glimpse of what might be the next best thing: an injectable drug that protects people for 6 months with each shot.
A large efficacy trial in African adolescent girls and young women reported in June that these shots reduced HIV infections to zero—an astonishing 100% efficacy.
Any doubts about the finding disappeared 3 months later when a similar trial, conducted across four continents, reported 99.9% efficacy in gender diverse people who have sex with men.
Read the full article.
Lenacapavir, a new drug being tested to prevent HIV, successfully prevented infection in 100% of patients tested in clinical
Leave a Reply